Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TCRX
$0.37
-44.63%
TCRX
· TScan Therapeutics, Inc.
$0.37
-0.30 (-44.63%)
At close · Sep 2
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 12, 2026
Market Cap
$28.41M
Shares
67.78M
All earnings calls
Earnings call · FY2025 Q1
TScan Therapeutics, Inc. (TCRX) Q1 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$2.17M
+283.6% YoY
Diluted EPS
-$0.26
Net income
-$34.13M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 6, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed May 6, 2025 · complete as-filed document